DePuy Synthes Down 7.5%, Bracing For More Extreme Declines
DePuy Synthes declined 7.5% in 1Q20 due to the impact of the COVID-19 pandemic, with the worst expected to come in 2Q as procedures are deferred en masse. Apr 16, 2020
We've found 293 results
What Will 1Q20 Earnings Tell Us about a COVID-19 Recovery?
First-quarter earnings announcements start in earnest today. We think a clearer picture of the entire orthopedic market could develop in the next month. Apr 14, 2020
How To Build A More Resilient Supply Chain Post COVID-19
Joint replacement surgeon Vinod Dasa, M.D., says there will be a heightened focus on eliminating waste and redundancies, especially in the “last mile” of the supply chain. Apr 09, 2020
Safe Orthopaedics Gains Japan Approval of Next-Gen SteriSpine PS
Safe Orthopaedics received regulatory approval of SteriSpine™ PS 2nd Generation in Japan. Mar 31, 2020
OrthoPediatrics Gains Expanded Indications for RESPONSE Scoliosis System
OrthoPediatrics was granted FDA 510(k) clearance to expand indications for the RESPONSE™ Scoliosis System to include neuromuscular implants. Mar 31, 2020
COVID-19 Orthopedic Company Updates
The COVID-19 pandemic is significantly disrupting the orthopedic market. We're tracking company updates to keep you abreast of ways that competitors and customers are reacting to COVID-19. Mar 24, 2020
Bone Therapeutics Gains Approval for Studies of OA Knee Pain Therapies
Bone Therapeutics received regulatory approvals for next studies of both of its lead therapeutic candidates to treat osteoarthritic knee pain. Mar 23, 2020
COVID-19 Impact: Procedure Deferrals Will Lead to Revenue Declines
After consulting with a host of industry veterans and observers, our guidance recommends that you expect and plan for business disruptions and revenue declines across the board—all companies, all market segments. Mar 20, 2020
AAOS Cancels 2020 Annual Meeting in Face of COVID-19 Concerns
The 2020 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) is canceled due to the ongoing spread of coronavirus. ORTHOWORLD wishes to reiterate our commitment to keep Members and subscribers apprised of the announcements to follow over the coming weeks. Mar 10, 2020
Omar Ishrak to Retire as CEO of Medtronic
Medtronic Chief Executive Officer Omar Ishrak announced his intention to retire in the beginning of 2Q20. Geoff Martha, currently Executive Vice President of MDT's Restorative Therapies Group, will assume the newly-created role of Medtronic President in 4Q19 and succeed Ishrak as CEO next year. Aug 28, 2019
